Dupilumab in Atopic Dermatitis - Rate of Poor Responders and Potential Risk Factors from the TREATgermany Registry.

Journal: Acta dermato-venereologica •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Heratizadeh A, Naim J, Kind B, et al. (2026). "Dupilumab in Atopic Dermatitis - Rate of Poor Responders and Potential Risk Factors from the TREATgermany Registry.". Acta dermato-venereologica. https://doi.org/10.2340/actadv.v106.adv-2026-0806